Last checked at 3 Dec 2009 07:00
| For immediate release | 3 December 2009 |
Oxford BioMedica Plc
Notification of Major Interest in Shares
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Oxford BioMedica Plc | ||
| 2. Reason for notification (yes/no) | |||
| An acquisition or disposal of voting rights | |||
| An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||
| An event changing the breakdown of voting rights | |||
| Other (please specify): See note 13 re Barclays' disposal of the Barclays Global Investors business | Yes | ||
| 3. Full name of person(s) subject to notification obligation: | Barclays PLC | ||
| 4. Full name of shareholder(s) (if different from 3): | Barclays Stockbrokers Ltd Gerrard Investment Management Ltd | ||
| 5. Date of transaction (and date on which the threshold is crossed or reached if different): | 1 December 2009 | ||
| 6. Date on which issuer notified: | 2 December 2009 | ||
| 7. Threshold(s) that is/are crossed or reached: | 7% to 5% | ||
| 8: Notified Details | |||||||
| A: Voting rights attached to shares | |||||||
| Class/type of shares If possible use ISIN code | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||
| Number of shares | Number of voting rights | Number of shares | Number of voting rights | Percentage of voting rights | |||
| Direct | Indirect | Direct | Indirect | ||||
| GB0006648157 | 39,831,749 | 39,831,749 | 32,357,983 | 0 | 32,357,983 | 0.00% | 5.98% |
| B: Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights |
| Total (A+B) | |
| Number of voting rights | Percentage of voting rights |
| 32,357,983 | 5.98% |
| 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
| Barclays Stockbrokers Ltd Gerrard Investment Management Ltd |
| Proxy Voting: | |
| 10. Name of proxy holder: | |
| 11. Number of voting rights proxy holder will cease to hold: | |
| 12. Date on which proxy holder will cease to hold voting rights: | |
| 13. Additional information: | On 1 December 2009, Barclays Group sold the Barclays Global Investors business, including Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors to BlackRock Inc. Accordingly, holdings of Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors are no longer attributable to the Barclays Group/Barclays plc and responsibility for making relevant shareholding disclosures relating to holdings of Barclays Global Investors Ltd, Barclays Global Investors (Deutschland) Ltd, Barclays Global Investors N.A. and Barclays Global Fund Advisors and other entities in the Barclays Global Investors business now lies with BlackRock. |
| 14 Contact name: | Andrew Wood |
| 15. Contact telephone name: | 01865 783000 |